Clinical trial of the BioFreedom drug coated stent in Japanese patients with coronary artery disease and a high risk of bleeding.

Trial Profile

Clinical trial of the BioFreedom drug coated stent in Japanese patients with coronary artery disease and a high risk of bleeding.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 11 Feb 2015

At a glance

  • Drugs Umirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms LEADERS Free Japan
  • Sponsors Biosensors International Group
  • Most Recent Events

    • 11 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top